Pfizer and Innovent Biologics Forge Major Global Oncology Partnership to Advance Next-Generation Cancer Medicines Pfizer Inc. and Innovent Biologics have announced a landmark strategic global licensing and collaboration agreement aimed at accelerating the discovery, development, and commercialization of a new…
BeOne Medicines Reports Phase 3 HERIZON-GEA Results Published in NEJM and Featured at ASCO 2026 BeOne Medicines has announced the publication and upcoming presentation of significant new clinical data from the HERIZON-GEA-01 trial evaluating ZIIHERA in combination with chemotherapy, with…
Cosm Medical Enters Licensing and Collaboration Agreement to Advance Personalized Gynethotics™ Devices for Post-Surgical Pelvic Recovery Cosm Medical Corp. has announced a new licensing and collaboration agreement with Duke Health and Mayo Clinic aimed at developing and commercializing a new…
New Research on Headache Treatments, Biomarkers, and the Gut-Brain Connection to Be Featured at the American Headache Society® 68th Annual Scientific Meeting American Headache Society is preparing to host its 68th Annual Scientific Meeting from June 4–7 at the Orlando…
Arrowhead Pharmaceuticals Unveils Encouraging Clinical Cardiometabolic Findings at the 94th European Atherosclerosis Society Congress Arrowhead Pharmaceuticals has presented new clinical findings supporting the broader use of plozasiran, its investigational small interfering RNA therapy targeting apolipoprotein C-III (APOC3), during two oral…
Aphios Corporation Receives Patent Allowance for Innovative Bryoid Composition Platform Aimed at Alzheimer’s, Multiple Sclerosis, HIV Reservoirs, and Oncology Applications Aphios Corporation has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for…
BreezeBio Establishes Scientific Advisory Board to Advance Precision Genetic Medicine Pipeline BreezeBio, formerly known as GenEdit, has announced the formation of its inaugural Scientific Advisory Board (SAB), marking a significant step in the company’s ongoing expansion as it advances a…
TFG-001 Shows Enhanced Neural Function and Reinnervation Potential in Parkinson’s Disease Cell Therapy Research TreeFrog Therapeutics has announced new preclinical findings for its investigational Parkinson’s disease cell therapy candidate, TFG-001, ahead of presentation at the 7th World Parkinson Congress. The…
Agios Secures EU Approval for PYRUKYND® (mitapivat) to Treat Adults Living with Thalassaemia, Announces Avanzanite Bioscience Avanzanite Bioscience B.V. has announced a major milestone in the treatment of rare blood disorders following the European Commission’s approval of PYRUKYND® (mitapivat) for…
Enhertu® Receives CHMP Recommendation for EU Approval in HER2-Positive Metastatic Solid Tumors Enhertu has received a positive recommendation for approval in the European Union from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for…
Veracyte to Present Practice-Changing Oncology Data at ASCO 2026 Highlighting Advances in Breast and Prostate Cancer Genomic Testing Veracyte announced that major new clinical data involving its Prosigna Breast and Decipher Prostate genomic tests will be presented during the 2026…
InSphero AG has acquired PhenoVista Biosciences, Inc. to strengthen its advanced 3D cell-based assay capabilities and expand translational research solutions. InSphero AG has announced the acquisition of PhenoVista Biosciences, Inc., a strategic move aimed at expanding capabilities in advanced drug…